Fund Holdings — Valence8 US LP

Total Portfolio Value:
$229.44M
Total Bought:
$33.09M
Total Sold:
$2.33M
Net Transaction:
+$30.76M
Notable People:
Valence8 Llc
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Ishares TrMSCI USA Quality Factor
MSCI USA QLT FCT
301,048337,472+36,424$51.41M$60.51M26.37%+$9.10M
Invesco Qqq TrUNIT SER 176,71188,149+11,438$36.75M$43.02M18.75%+$6.27M
Ishares TrMSCI International Quality
MSCI INTL QUALTY
892,1931,026,290+134,097$34.84M$42.58M18.56%+$7.74M
Ishares TrEAFE VALUE ETF399,186399,1860$21.17M$22.97M10.01%+$1.79M
Vanguard Index FdsVALUE ETF100,00396,630-3,373$16.04M$16.87M7.35%+$827.2K
Select Sector Spdr TrSBI CONS STPLS
ST STR STAPL ETF
168,300165,267-3,033$12.89M$13.72M5.98%+$828.7K
Ishares TrMSCI UK ETF NEW
MSCI UK ETF NEW
216,934209,344-7,590$7.57M$7.83M3.41%+$264.9K
Ishares IncMSCI Japan ETF
MSCI JAPAN ETF
108,634108,6340$7.41M$7.77M3.39%+$358.5K
Select Sector Spdr TrSBI INT UTILS
ST STR UTIL ETF
55,58851,940-3,648$3.79M$4.20M1.83%+$407.9K
Jazz Pharmaceuticals plcSHS USD(JAZZ)08,969+8,969$0$999.2K0.44%+$999.2K
Bristol-Myers Squibb Company(BMY)017,785+17,785$0$920.2K0.40%+$920.2K
Ascendis Pharma A/SADR(ASND)04,585+4,585$0$684.6K0.30%+$684.6K
Insmed Incorporated(INSM)07,865+7,865$0$574.1K0.25%+$574.1K
Indivior Plc057,293+57,293$0$564.2K0.25%+$564.2K
Eli Lilly and Company(LLY)0633+633$0$560.8K0.24%+$560.8K
argenx SEADR(ARGX)0953+953$0$516.6K0.23%+$516.6K
Soleno Therapeutics Inc09,706+9,706$0$490.1K0.21%+$490.1K
Keros Therapeutics, Inc.(KROS)08,025+8,025$0$466.0K0.20%+$466.0K
Nuvalent Inc04,115+4,115$0$421.0K0.18%+$421.0K
Janux Therapeutics, Inc.(JANX)07,857+7,857$0$356.9K0.16%+$356.9K
Crinetics Pharmaceuticals In06,684+6,684$0$341.6K0.15%+$341.6K
Tyra Biosciences, Inc.(TYRA)013,188+13,188$0$310.1K0.14%+$310.1K
Apogee Therapeutics Inc05,240+5,240$0$307.8K0.13%+$307.8K
Vaxcyte, Inc.(PCVX)02,468+2,468$0$282.0K0.12%+$282.0K
Intellia Therapeutics, Inc.(NTLA)013,020+13,020$0$267.6K0.12%+$267.6K
Vir Biotechnology, Inc.(VIR)033,650+33,650$0$252.0K0.11%+$252.0K
Blueprint Medicines Corp02,618+2,618$0$242.2K0.11%+$242.2K
Ultragenyx Pharmaceutical Inc.(RARE)04,241+4,241$0$235.6K0.10%+$235.6K
Enanta Pharmaceuticals, Inc.(ENTA)019,939+19,939$0$206.6K0.09%+$206.6K
Relay Therapeutics, Inc.(RLAY)026,200+26,200$0$185.5K0.08%+$185.5K
Zevra Therapeutics, Inc.(ZVRA)021,596+21,596$0$149.9K0.07%+$149.9K
Erasca, Inc.(ERAS)046,923+46,923$0$128.1K0.06%+$128.1K
Solid Biosciences Inc015,728+15,728$0$109.6K0.05%+$109.6K
Vistagen Therapeutics, Inc.(VTGN)034,376+34,376$0$103.5K0.05%+$103.5K
Zura Bio LimitedCL A(ZURA)017,495+17,495$0$71.0K0.03%+$71.0K
Alector Inc014,708+14,708$0$68.5K0.03%+$68.5K
Climb Bio, Inc.(CLYM)012,045+12,045$0$61.3K0.03%+$61.3K
Cypherpunk Technologies Inc.(CYPH)018,511+18,511$0$47.6K0.02%+$47.6K
Nektar Therapeutics(NKTR)026,107+26,107$0$33.9K0.01%+$33.9K
Kezar Life Sciences Inc021,136+21,136$0$16.3K0.01%+$16.3K
Page 1 of 1
Valence8 US LP — 13F Holdings — Q3 2024 | TickerTrail